PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.\', \'Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.\', \'Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.\', \'Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.\', \'Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA.\', \'Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.\', \'Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.\', \'Protein Chemistry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.\', \'Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University, Atlanta, GA 30322, USA.\', \'New York Blood Center, Lindsley F. Kimball Research Institute, New York, NY 10065, USA.\', \'Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.\', \'Skaggs Institute for Chemical Biology, Scripps Research Institute, La Jolla, CA, 92037, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1126/scitranslmed.abj5413
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 34519517
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
is ?:relation_isRelatedTo_publication of
?:title
  • Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all